Attributable Mortality of Nosocomial Candidemia, Revisited
The DOI matches its Crossref record; 35 of the 37 references it cites were found in a registry or an index.
Abstract
We reexamined the attributable mortality of nosocomial candidemia 15 years after a retrospective cohort study performed at our hospital demonstrated an attributable mortality of 38%. For all episodes of nosocomial candidemia between 1 July 1997 and 30 June 2001, we matched control patients with case patients by age, sex, date of hospital admission, underlying disease(s), length of time at risk, and surgical procedure(s). We analyzed 108 matched pairs. There were no statistically significant differences in age, sex, underlying disease(s), time at risk, surgical procedure, or vital signs at admission between cases and controls. The crude mortality among case patients was 61% (66 of 108 patients), compared with 12% (13 of 108) among control patients, for an attributable mortality of 49% (95% CI, 38%-60%). Nosocomial candidemia is still associated with an extremely high crude and attributable mortality--much higher than that expected from underlying disease alone.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These infections are associated with attributable mortality rates that have ranged from 38% between 1983 and 1986 (46) to 49% in the same institutions between 1997 and 2001 (13).”
In the citing paper
“Attributable mortality of candidiasis was evaluated retrospectively between 1997 and 2001 in 108 matched pairs [12], the crude mortality among case patients was 61% compared with 12% in controls; the resulting ''attributable mortality'' was therefore estimated to be 49%.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [12]
In the citing paper
“Studies on patients with IC have similarly shown excessive rates of inappropriate initial therapy and even higher mortality than infections caused by bacterial pathogens in the ICU setting.10,14,33,34,[42][43][44][45][46][47]”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [14]
In the citing paper
“Numerous reports have documented the association between inadequate dosing of antifungals in patients with IC and increased length of hospital stay, health care costs, morbidity, and mortality.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [14]
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Self-citationComparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Weinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Barth Reller, L. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,228
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Practice Guidelines for the Treatment of Candidiasis
Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Research works printed but not linked: 3
- Harvey, 1987, Archives of Internal Medicine, 147, 2117, 10.1001/archinte.1987.00370120053011 · doi:10.1001/archinte.1987.00370120053011
- Martin, 1989, Annals of Internal Medicine, 110, 9, 10.1059/0003-4819-110-1-9 · doi:10.1059/0003-4819-110-1-9
- O'Grady, 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control, 51, 1
Cited by
Items 201–300 of 1,000
Ferreira, J. A., Carr, J. H., Starling, C. E. F., de Resende, M. A., & Donlan, R. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00316-09 · Cited by 96
New signaling pathways govern the host response to C. albicans infection in various niches
Liu, Y., Shetty, A. C., Schwartz, J. A. J., Bradford, L. L., Xu, W., Phan, Q. T., Kumari, P., Mahurkar, A., Mitchell, A. P., Ravel, J., et al. (2015) · Genome Research · doi:10.5281/zenodo.13524844 · Cited by 96
Rajendran, R., Sherry, L., Deshpande, A., Johnson, E. M., Hanson, M., Williams, C., Munro, C. A., Jones, B., & Ramage, G. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00915 · Cited by 95
Extracellular proteinases of Candida species pathogenic yeasts
Rapala‐Kozik, M., Bochenska, O., Zajac, D., Karkowska‐Kuleta, J., Gogol, M., Zawrotniak, M., & Kozik, A. (2018) · Molecular Oral Microbiology · doi:10.1111/omi.12206 · Cited by 94
Complement and innate immune evasion strategies of the human pathogenic fungus Candida albicans
Luo, S., Skerka, C., Kurzai, O., & Zipfel, P. F. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.05.218 · Cited by 94
Wall, G., Chaturvedi, A. K., Wormley, F. L., Wiederhold, N. P., Patterson, H. P., Patterson, T. F., & Lopez-Ribot, J. L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01084-18 · Cited by 94
Ibrahim, A. S., Spellberg, B. J., Avanesian, V., Fu, Y., & Edwards, J. E. (2006) · Infection and Immunity · doi:10.1128/iai.74.5.3039-3041.2006 · Cited by 94
Cisterna, R., Ezpeleta, G., Telleria, O., Guinea, J., Regueiro, B., Garcia-Rodríguez, J., & Esperalba, J. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00920-10 · Cited by 72
RetractedGerami‐Nejad, M., Zacchi, L. F., McClellan, M., Matter, K. J., & Berman, J. G. (2013) · Microbiology · doi:10.1099/mic.0.064097-0 · Cited by 94
JALAL, M. S., Ansari, M. A., Ali, S. G., Khan, H. M., & Rehman, S. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1439837 · Cited by 94
Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries
Kaur, H., & Chakrabarti, A. (2017) · Journal of Fungi · doi:10.3390/jof3030041 · Cited by 93
Kim, H. S., Choi, E. H., Khan, J., Roilides, E., Francesconi, A., Kasai, M., Sein, T., Schaufele, R. L., Sakurai, K., Son, C. G., et al. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3714-3724.2005 · Cited by 76
Toward more effective antifungal therapy: the prospects of combination therapy
Kontoyiannis, D. P., & Lewis, R. E. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05007.x · Cited by 93
Leroy, G., Lambiotte, F., Thévenin, D., Lemaire, C., Parmentier, E., Devos, P., & Leroy, O. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-50 · Cited by 92
Interaction of Candida albicans with an Intestinal Pathogen, Salmonella enterica Serovar Typhimurium
Tampakakis, E., Peleg, A. Y., & Mylonakis, E. E. (2009) · Eukaryotic Cell · doi:10.1128/ec.00016-09 · Cited by 92
Supplement: Trends in invasive Candida infections and their treatment: focus on echinocandins
Lewis, R. E. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902990817 · Cited by 92
Slenker, A. K., Keith, S. W., & Horn, D. L. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.02.004 · Cited by 91
Warn, P. A., Sharp, A., Parmar, A., Majithiya, J., Denning, D. W., & Hope, W. W. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01601-08 · Cited by 86
Time to blood culture positivity as a marker for catheter-related candidemia
Ben-Ami, R., Weinberger, M., Orni-Wasserlauff, R., Schwartz, D., Itzhaki, A., Lazarovitch, T., Bash, E., Aharoni, Y., Moroz, I., & Giladi, M. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00214-08 · Cited by 90
“The estimated attributable outcomes of candidemia include excess mortality of 14% to 49% (5, 19), prolongation of hospital stay by 10 days (19), and increased expenditure of around 40,000 dollars per case (19).”
BackgroundGunsalus, K. T. W., Tornberg-Belanger, S. N., Matthan, N. R., Lichtenstein, A. H., & Kumamoto, C. A. (2015) · mSphere · doi:10.1128/msphere.00020-15 · Cited by 90
Lee, E. K. S., Gillrie, M. R., Li, L., Arnason, J. W., Kim, J. H., Babes, L., Lou, Y., Sanati-Nezhad, A., Kyei, S. K., Kelly, M. M., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2017.11.009 · Cited by 89
“ Candida Albicans Interactions With The Host: Crossing The Intestinal Epithelial Barrier”
Basmaciyan, L., Bon, F., Paradis, T., Lapaquette, P., & Dalle, F. (2019) · Tissue Barriers · doi:10.1080/21688370.2019.1612661 · Cited by 89
Candidaemia in internal medicine departments: the burden of a rising problem
Bassetti, M., Molinari, M. P., Mussap, M., Viscoli, C., & Righi, E. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12155 · Cited by 89
Spellberg, B. J., Ibrahim, A. S., Avenissian, V., Filler, S. G., Myers, C. L., Fu, Y., & Edwards, J. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.9.6191-6193.2005 · Cited by 89
Delattin, N., Brucker, K. D., Vandamme, K., Meert, E. M. K., Marchand, A., Chaltin, P., Cammue, B. P. A., & Thevissen, K. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt449 · Cited by 89
Robles, J. C., Koreen, L., Park, S., & Perlin, D. S. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2480-2488.2004 · Cited by 88
Candida albicans escapes from mouse neutrophils
Ermert, D., Niemiec, M. J., Röhm, M., Glenthøj, A. B., Borregaard, N., & Urban, C. F. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0213063 · Cited by 87
dos Santos, U. P., Campos, J. F., Torquato, H. F. V., Paredes‐Gamero, E. J., Carollo, C. A., Estevinho, L. M., Souza, K. D. P., & dos Santos, E. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167531 · Cited by 87
Variable recognition ofCandida albicansstrains by TLR4 and lectin recognition receptors
Netea, M. G., Gow, N. A. R., Joosten, L. A. B., Verschueren, I., van der Meer, J. W. M., & Kullberg, B. J. (2010) · Medical Mycology · doi:10.3109/13693781003621575 · Cited by 86
Rodriguez-Suarez, R. J., Xu, D., Veillette, K., Davison, J., Sillaots, S., Kauffman, S., Hu, W., Bowman, J. C., Martel, N., Trosok, S., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.09.009 · Cited by 86
Methods of Controlling Invasive Fungal Infections Using CD8+ T Cells
Kumaresan, P. R., da Silva, T. A., & Kontoyiannis, D. P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01939 · Cited by 85
“Invasive candidiasis (Candida) 8–10 cases/100,000 (16, 17) Cutaneous”
Zipfel, P. F., Skerka, C., Kupka, D., & Luo, S. (2011) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2011.04.010 · Cited by 85
Management of Invasive Candidiasis in Critically Ill Patients
Blot, S. I., & Vandewoude, K. (2004) · Drugs · doi:10.2165/00003495-200464190-00002 · Cited by 84
Moellering, R. C., Graybill, J. R., McGowan, J. E., & Corey, L. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.04.001 · Cited by 84
Lohse, M. B., Hernday, A. D., Fordyce, P. M., Noiman, L., Sorrells, T. R., Hanson-Smith, V., Nobile, C. J., DeRisi, J. L., & Johnson, A. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221734110 · Cited by 84
Studies on the antifungal properties of N-thiolated β-lactams
O’Driscoll, M., Greenhalgh, K., Young, A., Turos, E., Dickey, S. S., & Lim, D. V. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.06.035 · Cited by 84
Yang, S.-P., Chen, Y.-Y., Hsu, H., Wang, F., Chen, L.-Y., & Fung, C.-P. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-10 · Cited by 84
van de Veerdonk, F. L., Joosten, L. A. B., Devesa, I., Mora‐Montes, H. M., Kanneganti, T., Dinarello, C. A., van der Meer, J. W. M., Gow, N. A. R., Kullberg, B. J., & Netea, M. G. (2009) · The Journal of Infectious Diseases · doi:10.1086/597274 · Cited by 77
Ibrahim, A. S., Spellberg, B. J., Avenissian, V., Fu, Y., Filler, S. G., & Edwards, J. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.999-1005.2005 · Cited by 83
“The mortality attributable to disseminated candidiasis is 40 to 50%, even with modern antifungal therapy (16, 34, 40, 65).”
BackgroundLuo, S., Blom, A. M., Rupp, S., Hipler, U., Hube, B., Skerka, C., & Zipfel, P. F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.130138 · Cited by 83
Pahwa, N., Kumar, R., Nirkhiwale, S., & Bandi, A. (2014) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.124300 · Cited by 83
Mukherjee, P. K., Long, L. A., Kim, H., & Ghannoum, M. A. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.07.030 · Cited by 83
de Medeiros, M. A. P., de Melo, A. P. V., Bento, A. D. O., de Souza, L. B. F. C., Neto, F. D. A. B., Garcia, J. B.-L., Zuza-Alves, D. L., Francisco, E. C., Melo, A. S. D. A., & Chaves, G. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221033 · Cited by 83
Recognition ofCandida albicansby Mannan‐Binding Lectin In Vitro and In Vivo
Lillegard, J. B., Sim, R. B., Thorkildson, P., Gates‐Hollingsworth, M. A., & Kozel, T. R. (2006) · The Journal of Infectious Diseases · doi:10.1086/503804 · Cited by 83
Overview of vertebrate animal models of fungal infection
Hohl, T. M. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.03.022 · Cited by 83
Systems Biology of Fungal Infection
Horn, F., Heinekamp, T., Kniemeyer, O., Pollmächer, J., Valiante, V., & Brakhage, A. A. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00108 · Cited by 73
Fluconazole Assists Berberine To Kill Fluconazole-Resistant Candida albicans
Li, D., Xu, Y., Zhang, D., Quan, H., Mylonakis, E. E., Hu, D., Li, M.-B., Zhao, L., Liang-hua, Z. H. U., Wang, Y., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00499-13 · Cited by 82
State of Evidence on Oral Health Problems in Diabetic Patients: A Critical Review of the Literature
González‐Moles, M. Á., & Ramos‐García, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225383 · Cited by 81
Holley, A., Dulhunty, J. M., Blot, S. I., Lipman, J., Lobo, S. M., Dancer, C., Rello, J., & Dimopoulos, G. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.10.035 · Cited by 81
Goff, D. A., Jankowski, C. A., & Tenover, F. C. (2012) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.2012.01137.x · Cited by 81
Gene Overexpression/Suppression Analysis of Candidate Virulence Factors of Candida albicans
Fu, Y., Luo, G., Spellberg, B. J., Edwards, J. E., & Ibrahim, A. S. (2008) · Eukaryotic Cell · doi:10.1128/ec.00445-07 · Cited by 81
β-Glucan Is a Fungal Determinant for Adhesion-Dependent Human Neutrophil Functions
Lavigne, L. M., Albina, J. E., & Reichner, J. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8667 · Cited by 80
Epidemiology and predictors of a poor outcome in elderly patients with candidemia
Guimarães, T., Nucci, M., de Mendonça, J. S., Martínez, R., Brito, L. R., Silva, N., Moretti, M. L., Salomão, R., & Colombo, A. L. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.02.005 · Cited by 79
Novel strategies to fightCandidaspecies infection
Rodrigues, M. E., Silva, S. M., Azeredo, J., & Henriques, M. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2014.974500 · Cited by 78
Shin, J. H., Bougnoux, M., d’Enfert, C., Kim, S. H., Moon, C.-J., Joo, M. Y., Lee, K., Kim, M., Lee, H. S., Shin, M., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02153-10 · Cited by 78
Self-citationNosocomial infection surveillance and control policies
Gastmeier, P. (2004) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000136929.75543.8a · Cited by 78
The value of amphotericin B in the treatment of invasive fungal infections
Klepser, M. E. (2010) · Journal of Critical Care · doi:10.1016/j.jcrc.2010.08.005 · Cited by 77
Management bundles for candidaemia: the impact of compliance on clinical outcomes
Takesue, Y., Ueda, T., Mikamo, H., Oda, S., Takakura, S., Kitagawa, Y., KOHNO, S., on behalf of the ACTIONs Project, Masuda, A., Yoshida, C., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku414 · Cited by 77
Candidemia in the Intensive Care Unit
Epelbaum, O., & Chasan, R. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.04.010 · Cited by 77
Candida Bloodstream Infections: Changes in Epidemiology and Increase in Drug Resistance
Kotey, F. C. N., Dayie, N. T. K. D., Tetteh‐Quarcoo, P. B., & Donkor, E. S. (2021) · Infectious Diseases Research and Treatment · doi:10.1177/11786337211026927 · Cited by 77
The human gut microbiome in health and disease: time for a new chapter?
Lee, J., Bays, D. J., Savage, H. P., & Bäumler, A. J. (2024) · Infection and Immunity · doi:10.1128/iai.00302-24 · Cited by 77
de Molina, F. J. G., León, C., Ruiz‐Santana, S., Saavedra, P., & the CAVA I Study Group (2012) · Critical Care · doi:10.1186/cc11388 · Cited by 76
Bench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unit
Bassetti, M., Mikulska, M., & Viscoli, C. (2010) · Critical Care · doi:10.1186/cc9239 · Cited by 76
Sendid, B., Cotteau, A., François, N., d’Haveloose, A., Standaert‐Vitse, A., Camus, D., & Poulain, D. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-80 · Cited by 76
Echinocandins: A ray of hope in antifungal drug therapy
Grover, N. (2010) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.62396 · Cited by 75
“[1,2] Although C. albicans is the most commonly found isolate, patients infected with C. albicans-show the highest mortality.”
Wille, M. P., Guimarães, T., Furtado, G. H. C., & Colombo, A. L. (2013) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762013000300005 · Cited by 75
Arastehfar, A. A., Daneshnia, F., Najafzadeh, M. J., Hagen, F., Mahmoudi, S., Salehi, M., Zarrinfar, H., Namvar, Z., Zareshahrabadi, Z., Khodavaisy, S., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00206 · Cited by 76
Molecular Methods for the Diagnosis of Invasive Candidiasis
Camp, I., Spettel, K., & Willinger, B. (2020) · Journal of Fungi · doi:10.3390/jof6030101 · Cited by 75
Canadian Clinical Practice Guidelines for Invasive Candidiasis in Adults
Bow, E. J., Evans, G. A., Fuller, J., Laverdière, M., Rotstein, C., Rennie, R. P., Shafran, S. D., Sheppard, D. C., Carle, S., Phillips, P., et al. (2010) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2010/357076 · Cited by 74
Management of candidiasis in the intensive care unit
Schelenz, S. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm430 · Cited by 74
Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection
Klevay, M. J., Ernst, E. J., Hollanbaugh, J. L., Miller, J. G., Pfaller, M. A., & Diekema, D. J. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.10.001 · Cited by 73
Self-citationB, V. H., Bruynseels, P., Bensaid, M., Boekhout, T., Baere, T. D., Surmont, I., & Mertens, A. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1383-y · Cited by 73
In vitro antifungal activity of the berberine and its synergism with fluconazole
Iwazaki, R. S., Endo, E. H., Ueda‐Nakamura, T., Nakamura, C. V., Garcia, L. B., & Filho, B. P. D. (2009) · Antonie van Leeuwenhoek · doi:10.1007/s10482-009-9394-8 · Cited by 73
Aquino, V. R., Lunardi, L. W., Goldani, L. Z., & Barth, A. L. (2005) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702005000500009 · Cited by 73
Harris, M. R., Mora-Montes, H. M., Gow, N. A. R., & Coote, P. J. (2009) · Microbiology · doi:10.1099/mic.0.026120-0 · Cited by 73
Wang, J.-F., Xue, Y., Zhu, X.-B., & Fan, H. Z. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2287-4 · Cited by 72
Candidemia is Costly--Plain and Simple
Fridkin, S. K. (2005) · Clinical Infectious Diseases · doi:10.1086/496935 · Cited by 72
UPC2 Is Universally Essential for Azole Antifungal Resistance in Candida albicans
Vasicek, E. M., Berkow, E. L., Flowers, S. A., Barker, K. S., & Rogers, P. D. (2014) · Eukaryotic Cell · doi:10.1128/ec.00221-13 · Cited by 71
Occurrence, presentation and treatment of candidemia
Mikulska, M., Del Bono, V., Ratto, S., & Viscoli, C. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.52 · Cited by 71
Sendid, B., Dotan, N., Nseir, S., Savaux, C., Vandewalle, P., Standaert‐Vitse, A., Zerimech, F., Guery, B. P., Dukler, A., Colombel, J., et al. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00200-08 · Cited by 71
Activity of crude extracts from Brazilian cerrado plants against clinically relevant Candida species
Correia, A. F., Silveira, D., Fonseca-Bazzo, Y. M., Magalhães, P. O., Fagg, C. W., da Silva, E. C., Gomes, S. M., Gandolfi, L., Pratesi, R., & Nóbrega, Y. K. D. M. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1164-3 · Cited by 71
Moretti, M. L., Trabasso, P., Lyra, L., Fagnani, R., Resende, M. R., de Oliveira Cardoso, L. G., & Schreiber, A. Z. (2013) · Medical Mycology · doi:10.3109/13693786.2012.708107 · Cited by 55
Clancy, C. J., Nguyen, M.-L., Cheng, S., Huang, H., Fan, G.-X., Jaber, R. A., Wingard, J. R., Cline, C. L., & Nguyen, M. H. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02018-07 · Cited by 70
A Re-Evaluation of the Relationship between Morphology and Pathogenicity in Candida Species
Kadosh, D., & Mundodi, V. (2020) · Journal of Fungi · doi:10.3390/jof6010013 · Cited by 70
Horn, D. L., Ostrosky-Zeichner, L., Morris, M. I., Ullmann, A. J., Wu, C., Buell, D. N., Kovanda, L. L., & Cornely, O. A. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0843-0 · Cited by 69
Pryce, T. M., Palladino, S., Price, D. M., Gardam, D. J., Campbell, P. B., Christiansen, K., & Murray, R. J. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.11.002 · Cited by 69
Michallet, M., & Ito, J. I. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1178 · Cited by 69
Study of Candida albicans and its interactions with the host: A mini review
Tsai, P.-W., Chen, Y.-T., Hsu, P., & Lan, C. (2013) · Biomedicine · doi:10.1016/j.biomed.2012.12.004 · Cited by 69
Mazi, P. B., Olsen, M. A., Stwalley, D., Rauseo, A. M., Ayres, C., Powderly, W. G., & Spec, A. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac004 · Cited by 68
Li, R., Kumar, R., Tati, S., Puri, S., & Edgerton, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02295-12 · Cited by 60
Multilocus Sequence Typing for Analyses of Clonality of Candida albicans Strains in Taiwan
Chen, K.-W., Chen, Y., Lo, H., Odds, F. C., Wang, T.-H., Lin, C.-Y., & Li, S.-Y. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00320-06 · Cited by 68
Pfaller, M. A., Rhomberg, P. R., Wiederhold, N. P., Gibas, C. F. C., Sanders, C. J., Fan, H., Mele, J., Kovanda, L. L., & Castanheira, M. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01230-18 · Cited by 68
Self-citationNosocomial Candidemia: An Ounce of Prevention Is Better Than a Pound of Cure
Diekema, D. J., & Pfaller, M. A. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502451 · Cited by 67
Self-citationGarey, K. W., Pai, M. P., Suda, K. J., Turpin, R. S., Rege, M., Mingo, D. E., & Bearden, D. T. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1365 · Cited by 67
Fungal Infections in Transplant and Oncology Patients
Person, A. K., Kontoyiannis, D. P., & Alexander, B. D. (2010) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.01.002 · Cited by 67
Gao, H., Evans, T. W., & Finney, S. J. (2008) · Critical Care · doi:10.1186/cc6862 · Cited by 67
Echinocandins in the management of invasive fungal infections, part 2
Morris, M. I., & Villmann, M. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050464.p2 · Cited by 67
Schmalreck, A., Willinger, B., Haase, G., Blum, G., Lass‐Flörl, C., Fegeler, W., Becker, K., & for the Antifungal Susceptibility Testing (AFST) Study Group (2012) · Mycoses · doi:10.1111/j.1439-0507.2011.02165.x · Cited by 66
Improving the management of candidemia through antimicrobial stewardship interventions
Reed, E. E., West, J. E., Keating, E. A., Pancholi, P., Balada-Llasat, J.-M., Mangino, J. E., Bauer, K. A. A., & Goff, D. A. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.11.012 · Cited by 66
Moreira-Oliveira, M. S., Mikami, Y., Miyaji, M., Imai, T., Schreiber, A. Z., & Moretti, M. L. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-0041-7 · Cited by 66
Metadata
- Authors
- Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D.
- Affiliations
- University of Iowa Hospitals and Clinics (US)
- University of Iowa (US)
- Corresponding author
- Diekema, D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-11-01
- Volume
- 37
- Issue
- 9
- Pages
- 1172-1177
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2118236446
- Cited by
- 1,140
- References
- 37
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 22 · 2023: 30 · 2022: 35 · 2021: 34 · 2020: 35 · 2019: 38 · 2018: 35 · 2017: 51 · 2016: 41 · 2015: 59 · 2014: 74 · 2013: 76 · 2012: 60
- FWCI
- 26.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- nosocomial candidemia, attributable mortality, candidemia, mortality, matched case-control comparison, underlying disease, risk factors, nosocomial infections
- MeSH terms
- Age Factors, Antifungal Agents, Candida, Candidiasis, Cross Infection, Female, Humans, Length of Stay, Male, Microbial Sensitivity Tests, Middle Aged, Retrospective Studies, Sex Factors, Cohort Studies, Fluconazole, Survival Rate, Fungemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.